Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Dementia II: Tracer Properties, Evaluation Methods

  • You have access
    Semi-quantitative visual rating of Florpiramine F 18 (18F-AV -45) PET scans
    Daniel Skovronsky, Mark Mintun, Alan Carpenter, Chris Clark, Abhinay Joshi, Franz Hefti and Michael Pontecorvo
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 425;
  • You have access
    The effect of partial volume effect correction on PIB and FDG PET data in MCI and AD patients
    Tohru Shiga, Isabelle Miederer, Ken Herrmann, Gjermund Henriksen, Christine Praus, Markus Schwaiger and Alexander Drzezga
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 428;
  • You have access
    Relationship of cerebrospinal fluid biomarkers with in vivo [11C]PIB and [18F]FDDNP binding
    Nelleke Tolboom, Wiesje van der Flier, Maqsood Yaqub, Ronald Boellaard, Rien Blankenstein, Gert Luurtsema, Bert Windhorst, Philip Scheltens, Adriaan Lammertsma and Bart van Berckel
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 423;
  • You have access
    Kinetic modeling of BAY 94-9172 binding to β-amyloid in human brains using PET data
    G Becker, H Barthel, J Luthardt, M Patt, E Hammerstein, C Reininger, B Rohde, U Hegerl, H Gertz and O Sabri
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 424;
  • You have access
    Metabolic heterogeneity in ADNI PET subjects
    Frank Thiele, Fabian Wenzel, Stewart Young, Donna Cross, Ralph Buchert and Satoshi Minoshima
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 429;
  • You have access
    Comparison of semi-quantitative approaches for the clinical routine use of 11C-PIB PET
    Su Jin Kim, Jae Sung Lee, Yu Kyeong Kim, June-Key Chung, Myung Chul Lee and Dong Soo Lee
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 427;
  • You have access
    [C-11]BF-227 PET imaging of amyloid deposition in AD, MCI, and normal subjects
    Takashi Kato, Kengo Ito, Kentaro Hatano, Akinori Nakamura, Nobuyuki Okamura and Kazuhiko Yanai
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 426;
SNMMI

© 2025 SNMMI

Powered by HighWire